Navigation Links
CutisPharma Expands Product Line with New Oral Suspension Prescription Compounding Kits
Date:1/19/2012

WOBURN, Mass., Jan. 19, 2012 /PRNewswire/ -- CutisPharma, Inc. announced the introduction of FIRST® - Omeprazole and FIRST® - Lansoprazole Unit-of-Use oral suspension compounding kits. These new kits will help pharmacists dispense these compounded prescriptions containing widely used proton pump inhibitors (PPIs). Traditionally, compounded omeprazole and lansoprazole oral suspensions can take up to several hours to prepare and are quite unpleasant to the taste.  With FIRST® - Omeprazole and FIRST® - Lansoprazole, pharmacists need only add the liquid suspension to the powder, shake, and then within minutes can dispense to the patient with improved flavoring.

"We invested a lot of time to develop these new suspension kits.  The results are a pleasant tasting strawberry flavored medication with adequate stability once compounded," said Dr. Indu Muni, founder, chairman, and CEO of CutisPharma, Inc.  "These products offer another advantage for hospital use; since the suspensions are made using powders, and not pellets, our new compounded suspensions will flow more easily through nasogastric (NG) tubes, with minimal clogging compared to current practice. Also, our three different sizes of packaging, 3oz, 5oz, and 10oz, provide considerable prescribing flexibility."

FIRST® products save dispensing time, and can be compounded by the pharmacist while the patient waits, increasing customer satisfaction.  Using FIRST® - Omeprazole and FIRST® - Lansoprazole kits, the pharmacist can compound a prescription faster than those prepared in the conventional way.  A single NDC number assigned for the entire Kit facilitates the third party reimbursement process, and reduces audit-related adjustments.

CutisPharma now has twenty proprietary prescription compounding kits on the market: five progesterone suppository compounding kits, two testosterone kits, one hydrocortisone kit, six Magic Mouthwash k
'/>"/>

SOURCE CutisPharma, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
2. Centrix Pharmaceutical, Inc. Announces Agreement With CutisPharma, Inc. to Promote FIRST® - Progesterone VGS Compounding Kit
3. CutisPharma Launches New Prescription Mouthwash Kits Expanding Product Line
4. CutisPharma Announces Issuance of an Additional Patent for Suppository Compounding
5. Myoderm Expands International Capabilities
6. FDA Expands Use of Endovascular Graft to Treat Aortic Tears
7. Particle Sciences Expands Its DOSE™ Program With Additional Proprietary Modeling Capabilities
8. FDA Expands Use of Prevnar 13 Vaccine for People Ages 50 and Older
9. Inspiration Biopharmaceuticals Expands Leadership Team with Four New Hires
10. FDA Expands Use of HIV Drug Isentress to Children and Adolescents
11. Radient Pharmaceuticals Corporation Expands Distribution of Onko-Sure® in Asia; Receives Payment on First Order of 60 Kits
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... , July 11, 2014 ... Market Research "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, ... Growth, Trends and Forecast, 2013-2019" the global endoscopy devices ... and is expected to grow at a CAGR of ... value of USD 36.9 billion in 2019. ...
(Date:7/11/2014)... , July 11, 2014  Veran ... company, announced today the positive, cost-effective final ... innovative SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous ... a percutaneous approach to biopsy when a ... patients and physicians experience positive financial outcomes ...
(Date:7/11/2014)... 2014 Neurelis, Inc. ("Neurelis") today announced an ... option held by Biotie to purchase Neurelis, clearing the ... (intranasal diazepam) for pediatric and adult epilepsy patients who ... year, Biotie has advanced the development program for NRL-1 ... clinical work required for NDA submission to the FDA.  ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Veran Medical Publishes Lung Cancer Patient Management Study 2Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3
... of Hypertension,s Twenty-Third ... Annual Scientific Meeting - A cumulative forty-five percent ... of BENICAR(R) (olmesartan medoxomil), and BENICAR HCT(R) (olmesartan medoxomil/hydrochlorothiazide) achieved ... normotension (< 120/80 mm Hg) (placebo:1.4%)., - Eight out of 10 (cumulative ...
... Florida and Scripps Research in La ... ... and LA JOLLA, Calif., May 14 /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. ... Scripps Research,Institute, a non-profit biomedical research organization, today announced,that an agreement ...
Cached Medicine Technology:New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 2New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 3New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 4New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 5New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 6New Data Shows 45 Percent of Patients with Stage 1 Hypertension Reached Normotension with BENICAR(R) and BENICAR HCT(R) 7Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4
(Date:7/14/2014)... 14, 2014 Many diet plans often recommend ... by the School of Public Health at the University of ... a near-zero effect on weight loss. Now experts are suggesting ... some form of portion control to trigger measurable ... portions and controlling how much is consumed, simply by using ...
(Date:7/14/2014)... WA (PRWEB) July 14, 2014 Sometimes, ... up company Passionate Playground announces its first product release, ... pleasure product storage system. , Inventor and ... passionate consumers to have a storage solution for their ... the multibillion dollar adult retail industry. , Semer met ...
(Date:7/14/2014)... Germany (PRWEB) July 14, 2014 EurekaMag.com ... Hepatitis C which is a contagious liver disease ... a few weeks to a serious, lifelong illness that ... the United States have chronic Hepatitis C virus infection ... While the site's research category covers all studies ...
(Date:7/14/2014)... CA (PRWEB) July 14, 2014 "Medical ... every one of us. The Tri-Valley is a star ... Companies based in the region are working on amazing ... changing the face of medicine," according to Dale Kaye ... , To showcase some of the brilliant minds and ...
(Date:7/14/2014)... Doctor Mike Hamilton from Inception Chiropractic ... company website. The Inception website is a place for ... It's also a place for potential clients to learn ... When contacted at his office, Doctor Hamilton said, "We're ... website. Our site is obviously a great place for ...
Breaking Medicine News(10 mins):Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 2Health News:Increase Vegetable Consumption Has Zero Effect on Weight Loss – Portion Control is Recommended by Experts 3Health News:Passionate Playground launches Joyboxx 2Health News:Passionate Playground launches Joyboxx 3Health News:EurekaMag.com Publishes 64,900 New Studies on Hepatitis C 2Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 2Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 3Health News:Believing in the Possible – Innovation Tri-Valley’s Sixth Innovation Forum Examines the Tri-Valley’s Wealth of Innovators 4Health News:Doctor Mike Hamilton From Inception Chiropractic Websites Announces the Launch of Their New Website 2
... progressive degeneration of retinal ganglion cells and their axons ... to identify a way to stop or prevent the ... together a panel of 39 scientists to discuss the ... from the Fourth Annual ARVO/Pfizer Ophthalmics Research Institute Conference ...
... Regence praised President Barack Obama,s nominations this week of ... Services and Nancy-Ann DeParle as head of the White House ... Mark Ganz, president and CEO of Regence, the leading health ... to lead the U.S. Department of Health and Human Services, ...
... March 4 CVS Caremark Corporation (NYSE: ... has approved its quarterly dividend of $0.07625 per share ... 4, 2009 to holders of record on April 22, ... the largest provider of prescriptions in the nation. The ...
... lose fat instead of muscle. Not if you want to lower ... and heart disease. Not if you want to avoid cravings that ... want to keep the weight off long-term. , "Our latest study ... if you follow a diet that is moderately high in protein," ...
... increases the risk of stroke in patients with atrial fibrillation ... a new study by Kaiser Permanente researchers in the current ... been known that chronic kidney disease is a risk factor ... at whether chronic kidney disease independently increases risk of stroke ...
... Provider, Seeing More Than 250,000 Patients Per Year, ... March 4 Greenway Medical Technologies, a leading ... management and interoperability functionality, today announced that it ... Prime Suite (R) , into ...
Cached Medicine News:Health News:Experts examine causes, treatment and prevention of glaucoma 2Health News:Regence Praises Obama's Choice of Sebelius to Lead HHS, DeParle to Lead Health Reform Office 2Health News:Is one diet as good as another? U of I study says no and tells you why 2Health News:Is one diet as good as another? U of I study says no and tells you why 3Health News:Kidney disease increases the risk of stroke in patients 2Health News:Greenway Medical Technologies Partners With Pediatric Associates, the Nation's Largest Ambulatory Provider of General Pediatric Care 2Health News:Greenway Medical Technologies Partners With Pediatric Associates, the Nation's Largest Ambulatory Provider of General Pediatric Care 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: